Resultados de la búsqueda 2221-2230 of 20226 for WHO
The purpose of this study is to continue to provide olaratumab to eligible patients who are currently receiving olaratumab commercially for the treatment of ...
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
... who did not have cancer. The increased risk of HF is observed as early as one year from diagnosis of cancer and overall, 7% of patients develop CHF (median ...
PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision ...
Accessed Oct. 1, 2021. Finding a living donor. UNOS Transplant Living. https://transplantliving.org/kidney/who-are-living-donors/. Accessed Oct. 1, 2021. Risks.
Welcome to the AABIP―Who we are. American Association for Bronchology and Interventional Pulmonology. http://aabronchology.org/about/. Accessed Jan. 25 ...
... who have normal risk factors in order to improve the ability to diagnose and treat these cancers. We will use information in the medical record in this ...
The purpose of this study is to examine the microbiome and immune function in patients with active lymphoma, and in patients with a history of lymphoma who are ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?